FXTAS, SCA10, and SCA17 in American patients with movement disorders [1]

American Journal of Medical Genetics

Volumn 136 A, Issue 1, 2005, Pages 87-89

  Seixas, Ana I ^b,c   Maurer, Martin H ^b,d   Lin, Mark ^b   Callahan, Colleen ^b   Ahuja, Alka ^b   Matsuura, Tohru ^e   Ross, Christopher A ^b   Hisama, Fuki M ^f   Silveira, Isabel ^c   Margolis, Russell L ^a,b  

^a Meyer 2 181 ^*  (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADOLESCENT; ADULT; AGED; ATAXIA; CHILD; CLINICAL FEATURE; FAMILY HISTORY; FEMALE; FRAGILE X ASSOCIATED TREMOR ATAXIA SYNDROME; FXTAS GENE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HUMAN; HUNTINGTON CHOREA; LETTER; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SCA10 GENE; SCA17 GENE; SPINOCEREBELLAR ATAXIA TYPE 10; SPINOCEREBELLAR ATAXIA TYPE 17; TRINUCLEOTIDE REPEAT; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATAXIA; CHILD; CHILD, PRESCHOOL; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOVEMENT DISORDERS; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS; SPINOCEREBELLAR ATAXIAS; TATA-BOX BINDING PROTEIN; TREMOR; TRINUCLEOTIDE REPEAT EXPANSION; UNITED STATES;

ATAXIA;

EID: 21644486998     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.30761     Document Type: Letter

References (23)

1. Brown WT, Houck GE Jr., Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Brooks SS, Jenkins EC. 1993. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270:1569-1575.
2. Brussino A, Gellera C, Saluto A, Mariotti C, Arduino C, Castellotti B, Camerlingo M, de Angelis V, Orsi L, Tosca P, Migone N, Taroni F, Brusco A. 2005. FMR1 gene premutation is a frequent genetic cause of late-onset sporadic cerebellar ataxia. Neurology 64:145-147.
3. Cagnoli C, Michielotto C, Matsuura T, Ashizawa T, Margolis RL, Holmes SE, Gellera C, Migone N, Brusco A. 2004. Detection of large pathogenic expansions in FRDA1, SCA10, and SCA12 genes using a simple fluorescent repeat-primed PCR assay. J Mol Diagn 6: 96-100.
4. Dombrowski C, Levesque S, Morel ML, Rouillard P, Morgan K, Rousseau F. 2002. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 11:371-378.
5. Fahn S, Elton RL, UPDRS Development Committee. 1987. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease. Florham Park: Macmillam Healthcare Information, p 153-163, 293-304.
6. Garcia Arocena D, Breece KE, Hagerman PJ. 2003. Distribution of CGG repeat sizes within the fragile X mental retardation 1 (FMR1) homologue in a non-human primate population. Hum Genet 113:371-376.
7. Hagerman RJ, Hagerman PJ. 2002. The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev 12:278-283.
8. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ. 2001. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127-130.
9. Hagerman RJ, Leavitt BR, Farzin F, Jacquemont S, Greco CM, Brunberg JA, Tassone F, Hessl D, Harris SW, Zhang L, Jardini T, Gane LW, Ferranti J, Ruiz L, Leehey MA, Grigsby J, Hagerman PJ. 2004. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 74:1051-1056.
10. Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ. 2004. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291:460-469.
11. Koide R, Kobayashi S, Shimohata T, Ikeuchi T, Maruyama M, Saito M, Yamada M, Takahashi H, Tsuji S. 1999. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet 8:2047-2053.
12. Macpherson J, Waghorn A, Hammans S, Jacobs P. 2003. Observation of an excess of fragile-X premutations in a population of males referred with spinocerebellar ataxia. Hum Genet 112:619-620.
13. Margolis RL. 2002. The spinocerebellar ataxias: order emerges from chaos. Curr Neurol Neurosci Rep 2:447-456.
14. Matsuura T, Yamagata T, Burgess DL, Rasmussen A, Grewal RP, Watase K, Khajavi M, McCall AE, Davis CF, Zu L, Achari M, Pulst SM, Alonso E, Noebels JL, Nelson DL, Zoghbi HY, Ashizawa T. 2000. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 26:191-194.
15. Milunsky JM, Maher TA. 2004. Fragile X carrier screening and spinocerebellar ataxia in older males. Am J Med Genet 125A:320.
16. Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, Nagashima T, Ikeda S, Tsuji S, Kanazawa I. 2001. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 10:1441-1448.
17. Rasmussen A, Matsuura T, Ruano L, Yescas P, Ochoa A, Ashizawa T, Alonso E. 2001. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol 50:234-239.
18. Schols L, Bauer P, Schmidt T, Schulte T, Riess O. 2004. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3:291-304.
19. Tan EK, Zhao Y, Puong KY, Law HY, Chan LL, Yew K, Tan C, Shen H, Chandran VR, Teoh ML, Yih Y, Pavanni R, Wong MC, Ng IS. 2004. Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort. Neurology 63:362-363.
20. Teive HA, Roa BB, Raskin S, Fang P, Arruda WO, Neto YC, Gao R, Werneck LC, Ashizawa T. 2004. Clinical phenotype of Brazilian families with spinocerebellar ataxia 10. Neurology 63:1509-1512.
21. Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, Bryer A, Diener HC, Massaquoi S, Gomez CM, Coutinho P, Ben Hamida M, Campanella G, Filla A, Schut L, Timann D, Honnorat J, Nighoghossian N, Manyam B. 1997. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 145:205-211.
22. Van Esch H, Dom R, Bex D, Salden I, Caeckebeke J, Wibail A, Borghgraef M, Legius E, Fryns JP, Matthijs G. 2005. Screening for FMR-1 premutations in 122 older Flemish males presenting with ataxia. Eur J Hum Genet 13:121-123.
23. Zuhlke C, Budnik A, Gehlken U, Dalski A, Purmann S, Naumann M, Schmidt M, Burk K, Schwinger E. 2004. FMR1 premutation as a rare cause of late onset ataxiaEvidence for FXTAS in female carriers. J Neurol 251:1418-1419.